Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an announcement.
ResMed Inc, a company involved in the healthcare sector, has reported a change in beneficial ownership as per a recent filing. Jan De Witte, a director and 10% owner, acquired 1,073 shares of ResMed common stock through Restricted Stock Units (RSUs), which will vest in full by November 2026 or at the next annual stockholders’ meeting. This acquisition reflects the company’s ongoing commitment to aligning its leadership’s interests with those of its shareholders, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
For an in-depth examination of RMD stock, go to TipRanks’ Overview page.